FDA Investigator Erich P Garger
Erich P Garger has inspections in 2 countries as of 18 Oct 2023. Erich P Garger has collaborated with a combined 2087 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
83
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Indonesia
Co-Investigator(s):
Alan R Condon,
Alfred P Pistorio,
Alice C Silva,
Alois P Provost,
Alysia M Salonia,
Alyssa R Favro,
Amanda T Zick,
Amber G Wardwell,
Amy M Fitzpatrick,
Andrew P Abban,
Anne E Carpenter,
Annemarie L Buchholz,
Anthony P Costello,
Ashley M Whitehurst,
Ashley N Williams,
Atricia L Irons,
Barbara L Williams,
Bradford L Swanson,
Brandy L Couillard,
Brenda P King,
Brenna L Macdowell,
Carla C Tuite,
Christine L Williams,
Christine M Malone,
Christopher K Vantwuyver,
Christopher M Elliott,
Clinton V Giustra,
Dana A Razzano,
Darin S Wiegers,
Donna J Clevenger,
Douglas Florentino,
Douglas S Joslin,
Eduardo L Rodriguez,
Elise L Mcdevitt,
Emily J Schramm,
Erin P Conlin,
Frank J Koch,
Gerard D Difiore,
Hien Albright,
Intkhab H Wahla,
Irons,
Jamie S Mathews,
Jane Chen,
Janete F Guardia,
Jason D Tenney,
Jay M Patria,
Jeffery A Hangartner,
Jeffrey S Buckser,
John L Zaccone,
John P Shelton,
John R Carlson,
Jonathan B Lewis,
Jonathan G Matrisciano,
Joppie,
Joseph B Cascio,
Joseph Foley,
Joseph H Procopio,
Joshua L Gibbs,
Joyce A Kellett,
Kathleen A Sousa,
Kathleen E Mcafoose,
Kimberly J Langello,
Kimberly M White,
Kristina J Donohue,
Lauren M Lawrance,
Laurie B Frazier,
Liz M Otero,
Lorayne A Mcguinness,
Louis Christy,
M Patriciaurphy Murphy,
Marcia M Laughrey,
Mark E Farrell,
Martin J Guardia,
Mary Jeanet Mcgarry,
Maryam Tabatabaie,
Maxim,
Megan A Haggerty,
Michael E Antaya,
Michael G Mayfield,
Michael J Pasternak,
Michael P Sweeney,
Michelle M Noe,
Mikayla K Deardorff,
Milan S Mcgorty,
Nasser Yazdani,
Nicholas J Scire,
Nichole B Murphy,
Osama A Khatib,
Pamela L Ogonowski,
Patricia A Homola,
Patrick M Regan,
Peter R Caparelli,
Ramcharan S Khalsa,
Rebecca A Coleman,
Rebecca B Welch,
Remal,
Richard F Hapke,
Richard G Fochesato,
Richard L Licari,
Richard W Skodinski,
Robert D Ogan,
Rupa Pradhan,
Sean M Tessicini,
Shawn M Bogdan,
Slater K Bartlett,
State Agency,
Stefan Kaszycki,
Stephen C Smith,
Steven M Ferrara,
Teddy Tom,
Thomas Cote,
Thomas H Jenkins,
Thomas J Kelly,
Thomas Siebertz,
Thomas W Nerney,
Troy R Petrillo,
Victoria Taylor,
Wendy A Johnecheck,
William K Dagley
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more